534 related articles for article (PubMed ID: 21255942)
1. Feasibility of helical tomotherapy in stereotactic body radiation therapy for centrally located early stage non‒small-cell lung cancer or lung metastases.
Chi A; Jang SY; Welsh JS; Nguyen NP; Ong E; Gobar L; Komaki R
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):856-62. PubMed ID: 21255942
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
3. Analysis of dose distribution and risk of pneumonitis in stereotactic body radiation therapy for centrally located lung tumors: a comparison of robotic radiosurgery, helical tomotherapy and volumetric modulated arc therapy.
Kannarunimit D; Descovich M; Garcia A; Chen J; Weinberg V; Mcguinness C; Pinnaduwage D; Murnane J; Gottschalk AR; Yom SS
Technol Cancer Res Treat; 2015 Feb; 14(1):49-60. PubMed ID: 24325136
[TBL] [Abstract][Full Text] [Related]
4. 4π noncoplanar stereotactic body radiation therapy for centrally located or larger lung tumors.
Dong P; Lee P; Ruan D; Long T; Romeijn E; Low DA; Kupelian P; Abraham J; Yang Y; Sheng K
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):407-13. PubMed ID: 23523322
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of plan quality and treatment efficiency for single-isocenter/two-lesion lung stereotactic body radiation therapy.
Sanford L; Molloy J; Kumar S; Randall M; McGarry R; Pokhrel D
J Appl Clin Med Phys; 2019 Jan; 20(1):118-127. PubMed ID: 30548205
[TBL] [Abstract][Full Text] [Related]
6. Critical structure sparing in stereotactic ablative radiotherapy for central lung lesions: helical tomotherapy vs. volumetric modulated arc therapy.
Chi A; Ma P; Fu G; Hobbs G; Welsh JS; Nguyen NP; Jang SY; Dai J; Jin J; Komaki R
PLoS One; 2013; 8(4):e59729. PubMed ID: 23577071
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric selection for helical tomotherapy based stereotactic ablative radiotherapy for early-stage non-small cell lung cancer or lung metastases.
Chi A; Liao Z; Nguyen NP; Xu J; Welsh JS; Jang SY; Howe C; Komaki R
PLoS One; 2012; 7(4):e35809. PubMed ID: 22558228
[TBL] [Abstract][Full Text] [Related]
8. Potential reduction of lung dose via VMAT with jaw tracking in the treatment of single-isocenter/two-lesion lung SBRT.
Pokhrel D; Sanford L; Halfman M; Molloy J
J Appl Clin Med Phys; 2019 May; 20(5):55-63. PubMed ID: 30955251
[TBL] [Abstract][Full Text] [Related]
9. Use of FDG-PET to guide dose prescription heterogeneity in stereotactic body radiation therapy for lung cancers with volumetric modulated arc therapy: a feasibility study.
de Figueiredo BH; Antoine M; Trouette R; Lagarde P; Petit A; Lamare F; Hatt M; Fernandez P
Radiat Oncol; 2014 Dec; 9():300. PubMed ID: 25534014
[TBL] [Abstract][Full Text] [Related]
10. Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer.
Register SP; Zhang X; Mohan R; Chang JY
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1015-22. PubMed ID: 20615629
[TBL] [Abstract][Full Text] [Related]
11. Technical Note: Dosimetric evaluation of Monte Carlo algorithm in iPlan for stereotactic ablative body radiotherapy (SABR) for lung cancer patients using RTOG 0813 parameters.
Pokhrel D; Badkul R; Jiang H; Kumar P; Wang F
J Appl Clin Med Phys; 2015 Jan; 16(1):5058. PubMed ID: 25679161
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive dosimetric planning comparison for early-stage, non-small cell lung cancer with SABR: fixed-beam IMRT versus VMAT versus TomoTherapy.
Xhaferllari I; El-Sherif O; Gaede S
J Appl Clin Med Phys; 2016 Sep; 17(5):329-340. PubMed ID: 27685129
[TBL] [Abstract][Full Text] [Related]
13. Fast arc delivery for stereotactic body radiotherapy of vertebral and lung tumors.
Ong CL; Verbakel WF; Dahele M; Cuijpers JP; Slotman BJ; Senan S
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e137-43. PubMed ID: 22365628
[TBL] [Abstract][Full Text] [Related]
14. FFF-VMAT for SBRT of lung lesions: Improves dose coverage at tumor-lung interface compared to flattened beams.
Pokhrel D; Halfman M; Sanford L
J Appl Clin Med Phys; 2020 Jan; 21(1):26-35. PubMed ID: 31859456
[TBL] [Abstract][Full Text] [Related]
15. Determining the Optimal Dose Prescription for the Planning Target Volume with Stereotactic Body Radiotherapy for Non- Small Cell Lung Cancer Patients.
Liu XJ; Lin XT; Yin Y; Chen JH; Xing LG; Yu JM
Asian Pac J Cancer Prev; 2016; 17(5):2573-7. PubMed ID: 27268632
[TBL] [Abstract][Full Text] [Related]
16. Role of On-Table Plan Adaptation in MR-Guided Ablative Radiation Therapy for Central Lung Tumors.
Finazzi T; Palacios MA; Spoelstra FOB; Haasbeek CJA; Bruynzeel AME; Slotman BJ; Lagerwaard FJ; Senan S
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):933-941. PubMed ID: 30928360
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
Wang L; Hayes S; Paskalev K; Jin L; Buyyounouski MK; Ma CC; Feigenberg S
Radiother Oncol; 2009 Jun; 91(3):314-24. PubMed ID: 19111362
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric comparison of two arc-based stereotactic body radiotherapy techniques for early-stage lung cancer.
Liu H; Ye J; Kim JJ; Deng J; Kaur MS; Chen ZJ
Med Dosim; 2015; 40(1):76-81. PubMed ID: 25499078
[TBL] [Abstract][Full Text] [Related]
19. ITV-Based Robust Optimization for VMAT Planning of Stereotactic Body Radiation Therapy of Lung Cancer.
Liang X; Zheng D; Mamalui-Hunter M; Flampouri S; Hoppe BS; Mendenhall N; Li Z
Pract Radiat Oncol; 2019 Jan; 9(1):38-48. PubMed ID: 30138747
[TBL] [Abstract][Full Text] [Related]
20. Development and clinical validation of a robust knowledge-based planning model for stereotactic body radiotherapy treatment of centrally located lung tumors.
Visak J; McGarry RC; Randall ME; Pokhrel D
J Appl Clin Med Phys; 2021 Jan; 22(1):146-155. PubMed ID: 33285034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
